Radius Health to Release First Quarter 2022 Financial Results, Host Conference Call and Live Webcast on Thursday, May 5, 2022

Rhea-AI Summary

Radius Health (Nasdaq: RDUS) is set to release its first quarter 2022 financial results on May 5, 2022. A conference call will be held at 8:30 a.m. ET to discuss the results and provide a business update. Interested parties can join via domestic dial-in number 1 (866) 323-7965 or internationally at 1 (346) 406-0961, using conference ID 5844208. The call will also be streamed live and archived for future access on Radius's website. This event underscores Radius's commitment to keeping investors informed on its financial performance.

Positive

• Scheduled financial results release may indicate transparency and commitment to shareholders.
• The live audio webcast allows for wider investor access and engagement.

Negative

• None.

BOSTON, April 25, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) announced today that it will release its first quarter 2022 financial results on Thursday, May 5, 2022. The Company will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the results and provide a business update.

Conference Call Information:
Domestic Dial-In Number: 1 (866) 323-7965
International Dial-In Number: 1 (346) 406-0961
Conference ID: 5844208
Webcast Link: https://edge.media-server.com/mmc/p/nmcknbsv

A replay of the conference call will be available on May 5^th at 11:30 a.m. ET. A live audio webcast of the call will be archived on the Company's website for 12 months. To access the replay, dial (855) 859-2056 or (404) 537-3406 for International, using conference ID number 5844208. The live audio webcast of the call can be accessed from the Investors section of the Company’s website, https://ir.radiuspharm.com/events-and-presentations. The full text of the announcement and financial results will also be available on the Company’s website.

About Radius
Radius Health is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. Our team works collaboratively and relentlessly to advance our therapies; all with the goal of improving the lives of patients, their families, and their caregivers. The Radius portfolio consists of commercial and clinical development assets, including early to late-stage drug candidates. Find out more at www.radiuspharm.com.

Investor & Media Relations Contact:
Ethan Holdaway
Email: investor-relations@radiuspharm.com
Phone: (617) 583-2017

FAQ

When will Radius Health release its Q1 2022 financial results?

Radius Health will release its Q1 2022 financial results on May 5, 2022.

What time is the Radius Health conference call scheduled?

The conference call is scheduled for 8:30 a.m. ET on May 5, 2022.

How can I access the Radius Health conference call?

You can access the conference call by calling 1 (866) 323-7965 domestically or 1 (346) 406-0961 internationally, using conference ID 5844208.

Will the Radius Health conference call be available for replay?

Yes, a replay of the conference call will be available starting at 11:30 a.m. ET on May 5, 2022.

Where can I find more information about Radius Health?

Additional information can be found on Radius Health's website at www.radiuspharm.com.